U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT07467343) titled 'Silodosin vs Tamsulosin for LUTS Due to BPH: A Randomized Crossover Trial' on March 09.
Brief Summary: The goal of this randomized crossover clinical trial is to compare the efficacy and safety of Silodosin versus Tamsulosin in patients with moderate to severe lower urinary tract symptoms due to Benign Prostatic Hyperplasia. The main questions it aims to answer are:
Does Silodosin provide superior improvement in symptom scores (IPSS) compared to Tamsulosin?
Is there a difference in safety profile and adverse events between the two treatments?
Researchers will compare both treatments in a crossover design, where each participant ...